Lv41
520 积分 2024-06-07 加入
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
5小时前
已完结
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
5小时前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
14天前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
14天前
已完结
STEAP proteins: Roles in disease biology and potential for therapeutic intervention
1个月前
已完结
Enzymatic Amplification Staining for Cell Surface Antigens
2个月前
已完结
Signal amplification in flow cytometry for cell surface antigen analysis
2个月前
已完结
Bispecific Antibodies: An Emerging Concept in Antibody-Based Cancer Therapies
2个月前
已完结
The role and regulation of integrins in cell migration and invasion
3个月前
已完结
Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
3个月前
已完结
皖公网安备34019202002308
